Trially
Kansas City, US · Founded 2023 · Delaware corporation · 5 known investors
Trially uses AI and data science to match patients with clinical trials and accelerate trial recruitment. The platform targets research sites and trial sponsors seeking to reduce screening time and trial delays through HIPAA-compliant patient data analysis.
Founders & leadership
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$4.8MraisedAug 2025 · 13 investors · Other Health CareRule 506(b)
▶$4.8MraisedAug 2025 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thad LangfordDirector
- Kyle McAllisterExecutive Officer, Director
- Trevor WelchExecutive Officer, Director
- Offering amount
- $4.8M
- Amount sold
- $4.8M
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Trially AI: $4.7 Million Raised For AI-Based Clinical Trial Recruitment Platformpulse2.com · 2025
- Trially AI Raises $4.7M Seed Round, Launches AI for Clinical Trial Enrollmentbiopharmatrend.com · 2025
- Trially AI Raises $4.7M in Seed Fundingfinsmes.com · 2025
- Trially raises $4.7m to enhance trial recruitment with AIclinicaltrialsarena.com · 2025
- Trially secures $4.7M seed round, launches ‘Margo’ AI solution to clear patient bottleneck - Startland Newsstartlandnews.com · 2025
- Why We Invested In Trially. Trially is revolutionizing the clinical… | by Brett Calhoun | Redbud VC | Mediummedium.com · 2024

